![Lisa Carson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 104 340 $ as of 30/05/2026
Lisa Carson is currently Chief Financial Officer at Phio Pharmaceuticals Corp.
since 2026.
Formerly, Ms. Carson was Vice President-Finance & Controller at Prelude Therapeutics, Inc. from 2021 to 2024.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/02/2026 | 94,000 ( 0.81% ) | 104 340 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Director of Finance/CFO | 08/06/2025 |
| Companies | Position | End |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Comptroller/Controller/Auditor | 31/10/2024 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Phio Pharmaceuticals Corp.
 Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
